Objective: Measurement of medial temporal lobe atrophy (MTL) by computerised tomography (CT) may be a useful adjunct to the diagnosis of AD. The aim of this study was to assess the sensitivity, specificity, predictive values and diagnostic accuracy of CT measurement of MTL thickness for patients with probable AD, compared with a 'diseased' control group, and to correlate the measure with neuropsychological test scores.
Design: Cross-sectional.
Methods: One hundred subjects were prospectively recruited: 60 with probable AD (mean age 73.7 years, mean Mini-Mental State Examination [MMSE] 19.6), 17 with probable vascular dementia (VaD) (mean age 77.9 years, mean MMSE 20.9), 14 with depression (mean age 73.2 years, mean MMSE 25.7) and nine with paraphrenia (mean age 74 years, mean MMSE 25.4). Axial and temporal lobe-oriented CT brain was performed and the minimum MTL thickness was measured electronically.
Results: The mean minimum MTL thickness was significantly smaller in AD subjects compared to VaD (p<0.0001) and psychiatric subjects (p<0.0001). For the clinical diagnosis of probable AD, the sensitivity of the measure was 0.75, specificity 0.9, and diagnostic accuracy 0.81. For the mildest cases of AD (CDR 0.5), the sensitivity of the measure was 0.61, specificity 0.91, and diagnostic accuracy 0.81. No significant correlations with neuropsychological test scores were found.
Conclusions: Temporal lobe-oriented CT imaging is a non-invasive test with good discrimination for AD. Potential uses of this technique include as an aid to diagnosis and possibly as a means of monitoring disease progression.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/(sici)1099-1166(200004)15:4<306::aid-gps111>3.0.co;2-q | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Posterior hippocampal sparing in Lewy body disorders with Alzheimer's copathology: An in vivo MRI study.
Neuroimage Clin
December 2024
Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Electronic address:
Background: Lewy body disorders (LBD), encompassing Parkinson disease (PD), PD dementia (PDD), and dementia with Lewy bodies (DLB), are characterized by alpha-synuclein pathology but often are accompanied by Alzheimer's disease (AD) neuropathological change (ADNC). The medial temporal lobe (MTL) is a primary locus of tau accumulation and associated neurodegeneration in AD. However, it is unclear the extent to which AD copathology in LBD (LBD/AD+) contributes to MTL-specific patterns of degeneration.
View Article and Find Full Text PDFThe prefrontal cortex, but not the medial temporal lobe, is associated with episodic memory in middle-aged persons with HIV.
J Int Neuropsychol Soc
December 2024
University of California San Diego, La Jolla, CA, USA.
Objective: Identifying persons with HIV (PWH) at increased risk for Alzheimer's disease (AD) is complicated because memory deficits are common in HIV-associated neurocognitive disorders (HAND) and a defining feature of amnestic mild cognitive impairment (aMCI; a precursor to AD). Recognition memory deficits may be useful in differentiating these etiologies. Therefore, neuroimaging correlates of different memory deficits (i.
View Article and Find Full Text PDFEffects of mixed metal exposures on MRI diffusion features in the medial temporal lobe.
Neurotoxicology
December 2024
Departments of Neurology, Pennsylvania State University-Milton S. Hershey Medical Center, Hershey, PA 17033, USA; Pharmacology, Pennsylvania State University-Milton S. Hershey Medical Center, Hershey, PA 17033, USA; Radiology, Pennsylvania State University-Milton S. Hershey Medical Center, Hershey, PA 17033, USA; Neurosurgery, Pennsylvania State University-Milton S. Hershey Medical Center, Hershey, PA 17033, USA; Kinesiology, Pennsylvania State University-Milton S. Hershey Medical Center, Hershey, PA 17033, USA; Department of Neurology, School of Medicine, University of Virgina, Charlottesville, VA 22908, USA. Electronic address:
Article Synopsis
- - The study investigates how exposure to mixed metals, particularly from welding fumes, is linked to brain structure and cognitive function, focusing on the medial temporal lobe (MTL) in 42 exposed individuals and 31 controls.
- - Results showed that those exposed to metals had altered brain metrics indicating poor processing speed and cognitive performance, resembling symptoms seen in Alzheimer's disease, although no significant changes in brain structure were observed.
- - The findings suggest that long-term exposure to metal mixtures could potentially lead to neurological changes similar to those seen in Alzheimer's risk groups, highlighting the need for further research on environmental impacts on brain health.
Association between large neutral amino acids and white matter hyperintensities in middle-aged adults at varying metabolic risk.
Brain Imaging Behav
December 2024
Department of Psychology, The University of Texas at Austin, 108 E. Dean Keeton Street, Stop A8000, Austin, TX, 78712, USA.
This investigation delves into the interplay between large neutral amino acids (LNAA) and metabolic syndrome (MetS) in midlife adults, examining their collective influence on brain structure. While LNAA, such as tryptophan and phenylalanine, are known to bolster cognition in youth, these relationships often reverse later in life. Our study hypothesized an earlier reversal of these benefits in middle-aged adults with MetS, potentially signaling premature brain aging.
View Article and Find Full Text PDFHypertension and cerebral blood flow in the development of Alzheimer's disease.
Alzheimers Dement
November 2024
Institute for Regenerative Medicine, University of Zurich, Zurich, Switzerland.
Introduction: We investigated the interactive associations between amyloid and hypertension on the entorhinal cortex (EC) tau and atrophy and the role of cerebral blood flow (CBF) as a shared mechanism by which amyloid and hypertension contribute to EC tau and regional white matter hyperintensities (WMHs).
Methods: We analyzed data from older adults without dementia participating in the Add-Tau study (NCT02958670, n = 138) or Alzheimer's Disease Neuroimaging Initiative (ADNI) (n = 523) who had available amyloid-positron emission tomography (PET), tau-PET, fluid-attenuated inversion recovery (FLAIR), and T1-weighted magnetic resonance imaging (MRI). A subsample in both cohorts had available arterial spin labeling (ASL) MRI (Add-Tau: n = 78; ADNI: n = 89).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!